TRILLIUM THERAPEUTICS INC - COM NEW

CUSIP: 89620X506

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Equity / COM NEW
Total 13F shares
3,189,049
Share change
-332,932
Total reported value
$29,496,000
Price per share
$9.25
Number of holders
28
Value change
-$3,218,720
Number of buys
12
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 89620X506?
CUSIP 89620X506 identifies 89620X506 - TRILLIUM THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TRILLIUM THERAPEUTICS INC - COM NEW as of Q1 2016

As of 31 Mar 2016, TRILLIUM THERAPEUTICS INC - COM NEW was held by 28 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,189,049 shares. The largest 10 holders included JANUS CAPITAL MANAGEMENT LLC, FRANKLIN RESOURCES INC, Point72 Asset Management, L.P., MILLENNIUM MANAGEMENT LLC, venBio Select Advisor LLC, BAKER BROS. ADVISORS LP, Opaleye Management Inc., DEERFIELD MANAGEMENT CO, EverPoint Asset Management, LLC, and OXFORD ASSET MANAGEMENT. This page lists 28 institutional shareholders reporting positions in this security for the Q1 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.